(Q45204753)

10 December 2017

0 references

1 reference

title

Treatment of amyloidosis and the rheumatologist. State of the art and perspectives for the future (English)

1 reference

10 December 2017

Husby G

1

1 reference

PubMed ID

9645409

10 December 2017

language of work or name

1 reference

1 January 1998

1 reference

Scandinavian Journal of Rheumatology

10 December 2017

1 reference

10 December 2017

27

1 reference

10 December 2017

3

1 reference

10 December 2017

161-165

1 reference

Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome

10 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

Fifteen years' experience with renal transplantation in systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

Dialysis arthropathy: outcome after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

Alzheimer's disease: genotypes, phenotypes, and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

Effectiveness of anthracycline against experimental prion disease in Syrian hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

Controlling amyloid beta-peptide fibril formation with protease-stable ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleu

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

Involvement of free radicals in dementia of the Alzheimer type: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097498440750

21 January 2018

Identifiers

DOI

10.1080/030097498440750

1 reference

10 December 2017

1 reference

PubMed ID

9645409